Iguh Chika, Kim Julie, Akaraonye Akudo, Minja Amani, Qing Xin
Department of Pathology and Laboratory Medicine, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
J Med Cases. 2025 Feb;16(2):48-54. doi: 10.14740/jmc5084. Epub 2025 Jan 9.
Primary effusion lymphoma (PEL) is a rare, aggressive large B-cell lymphoma variant that is invariably associated with human herpesvirus 8 (HHV8), predominantly in human immunodeficiency virus (HIV)-infected patients, and its oncogenicity is often augmented by coinfection with Epstein-Barr virus. It typically presents as a serous effusion in body cavities without detectable solid tumors. The extracavitary variant of PEL may represent a diagnostic challenge. A 37-year-old man with HIV/acquired immunodeficiency syndrome (AIDS) was transferred to our hospital for evaluation of a mediastinal mass with associated clinically diagnosed hemophagocytic lymphohistiocytosis (HLH), fever, pancytopenia, hepatosplenomegaly, retroperitoneal lymphadenopathy, and wasting syndrome. Contrast-enhanced computed tomography showed a large soft tissue mass extending along the middle/posterior mediastinum into the left hilum and a large left pleural effusion. Endoscopic fine-needle biopsy of the lesion showed sheets of large pleomorphic lymphoma cells with prominent nucleoli and abundant cytoplasm. These cells were also seen on the cytospin smear of pleural fluid. Immunohistochemical stains showed lymphoma cells positive for CD3 (small subset), CD45, CD138, MUM-1, and HHV8 and negative for CD5, CD20, CD30, ALK1, AE1/3, and PAX-5. The lymphoma cells were also positive for Epstein-Barr virus-encoded RNA (EBER) ( hybridization). Solid masses in extracavitary PEL have been shown to involve lymph nodes and/or solid organs such as the gastrointestinal tract, lung, liver, spleen, and skin, with a similar phenotype as classic PEL except that they may express B-cell markers with lower expression of CD45 and/or aberrant coexpression of T-cell antigens. This case illustrates the unusual manifestation of PEL as a mediastinal mass with associated HLH.
原发性渗出性淋巴瘤(PEL)是一种罕见的侵袭性大B细胞淋巴瘤变体,总是与人类疱疹病毒8型(HHV8)相关,主要见于人类免疫缺陷病毒(HIV)感染患者,其致癌性常因与爱泼斯坦-巴尔病毒合并感染而增强。它通常表现为体腔中的浆液性渗出液,无可检测到的实体瘤。PEL的腔外变体可能构成诊断挑战。一名37岁的HIV/获得性免疫缺陷综合征(AIDS)男性患者因纵隔肿块伴临床诊断的噬血细胞性淋巴组织细胞增生症(HLH)、发热、全血细胞减少、肝脾肿大、腹膜后淋巴结病和消瘦综合征被转诊至我院。增强计算机断层扫描显示一个大的软组织肿块沿中/后纵隔延伸至左肺门,并伴有大量左侧胸腔积液。病变的内镜细针活检显示大片大的多形性淋巴瘤细胞,核仁突出,细胞质丰富。这些细胞也见于胸腔积液的细胞涂片。免疫组织化学染色显示淋巴瘤细胞CD3(小部分)、CD45、CD138、MUM-1和HHV8阳性,CD5、CD20、CD30、ALK1、AE1/3和PAX-5阴性。淋巴瘤细胞也对爱泼斯坦-巴尔病毒编码RNA(EBER)呈阳性(杂交)。已证明腔外PEL中的实体肿块可累及淋巴结和/或实体器官,如胃肠道、肺、肝、脾和皮肤,其表型与经典PEL相似,只是它们可能表达B细胞标志物,CD45表达较低和/或T细胞抗原异常共表达。本病例说明了PEL作为伴有HLH的纵隔肿块的不寻常表现。